TG Therapeutics | TGTX - Trade Creditors



TG Therapeutics reported 134.02M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
AbbVie 2.94B 2.66B Dec/2024
Alaunos Therapeutics USD 516K 58K Dec/2024
Amgen USD 18.03B 15.63B Jun/2025
Ardelyx USD 21.68M 5.68M Jun/2025
Arrowhead Research USD 33.05M 23.07M Jun/2025
Bayer EUR 6.04B 549M Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
Corcept Therapeutics USD 23.52M 4.42M Jun/2025
Dynavax Technologies USD 2.7M 1.63M Jun/2025
Gilead Sciences USD 582M 155M Jun/2025
J&J USD 9.54B 766M Mar/2025
Novartis USD 4.51B 245M Jun/2025
PTC Therapeutics USD 206.31M 191.16M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Roche Holding 4.35B 828M Dec/2024
TG Therapeutics 134.02M 92.06M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025